Project Grant HT94252410548
Award Date 6/1/24
Completion Date 5/31/28
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- The federal Project Grant award of $1,552,867.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The award supports advanced biomedical research focused on the early detection of endometrial carcinoma through cell enrichment and flow cytometry. The performance period runs from Sep 30, 2025 to Sep 29, 2028. As a leading federal research institution, Johns Hopkins has a demonstrated track record of...
- This $1,637,500 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Johns Hopkins University to target specific PARP1 inhibition for breast cancer treatment. The award, which began on July 1, 2024 and will be completed by June 30, 2027, will enable the university to conduct innovative scientific studies ranging from basic laboratory research to advanced clinical trials focused on improving...
- This federal Project Grant award of $465,750.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Johns Hopkins University to investigate "ESTROGEN RECEPTOR MUTATIONS AS A NOVEL BIOMARKER FOR RESPONSE TO ENDOCRINE THERAPY IN OVARIAN CANCER". The award is effective from July 1, 2025 through June 30, 2027. The funded research aims to transform healthcare for military service members, veterans, and...
- This $1,473,750 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research study on "The Immunomodulatory Impact of Chemotherapy When Combined with PD-1 Blockade in Resectable Lung Cancer." The 3-year grant, running from September 1, 2024 to August 31, 2027, aims to investigate innovative immunological interventions for treating lung cancer in military service...
- The federal Project Grant award of $610,059.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Johns Hopkins University to investigate "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The award period runs from July 1, 2025 to June 30, 2028 and aims to advance biomedical research focused on transforming healthcare for military service members, veterans, and the broader public....
- This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
- The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
- This federal Project Grant award of $388,194 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research led by The Johns Hopkins University to investigate the aging microenvironment as a driver of pancreatic cancer metastasis. The 3-year project, beginning on July 1, 2025, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical research on critical health challenges....
- This federal Project Grant award of $360,413.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by The Johns Hopkins University focused on early hepatic dissemination of pancreatic cancer. The research aims to evaluate the efficacy of systemic chemotherapy-enhanced alpha-particle radiotherapy as a treatment approach. The award has a performance period from November 1, 2024 to October 31, 2027. As a leading academic...
- The University of Pittsburgh was awarded a $873,419 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to investigate stromal drivers of ovarian cancer initiation. The University will examine medical solutions for ovarian cancer through basic, applied, and advanced biomedical research efforts. A sub-award of $100,000 was also provided to The Johns Hopkins University to support this research project, which aims...